+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Search Bar & Filters

Found 22 Actively Recruiting clinical trials

O

Actively Recruiting

Researchers are studying the effects of orforglipron compared to a placebo in adults aged 50 and older who have atherosclerotic cardiovascular disease ASCVD andor chronic kidney disease CKD. This Phase 3 trial aims to evaluate how orforglipron impacts major cardiovascular events over about five years of participation. Participants will be randomly assigned to receive either orforglipron orally along with standard care or a placebo orally with standard care. The study is double-blind, meaning neither participants nor researchers know who receives the active drug or placebo. This design helps measure the drugs impact on cardiovascular health and kidney function over the study duration. During the study, participants will be monitored regularly to track the time to the first major cardiovascular event and other health outcomes such as kidney function changes and the onset of type 2 diabetes. The study involves ongoing assessments from baseline through the five-year period, including follow-ups to ensure safety and gather detailed health information.

Age: 50Years +All GendersPhase 3
566 locations
E

Actively Recruiting

Researchers are evaluating the efficacy and safety of the drug NNC0487-0111 in adults with excess body weight and moderate-to-severe obstructive sleep apnoea OSA who are not treated with positive airway pressure. This Phase 3 study randomizes participants to receive either NNC0487-0111 or a placebo to assess their ability to lose weight and improve sleep apnoea symptoms. Participants will receive weekly injections under the skin using pre-filled pen-injectors of either NNC0487-0111 or placebo. Both groups will follow a reduced-calorie diet and increase physical activity. The treatment period lasts 80 weeks, during which the effects on body weight and sleep apnoea will be monitored. During the study, participants will have regular assessments including measurements of body weight, apnoea-hypopnoea index AHI, sleepiness scales, blood pressure, cholesterol levels, blood sugar, and other health indicators. Safety will be monitored through tracking adverse events up to 84 weeks. The study aims to measure changes from baseline to week 80 to evaluate treatment impact.

Age: 18Years +All GendersPhase 3
80 locations
S

Actively Recruiting

Researchers are evaluating the efficacy and safety of a medicine called NNC0487-0111 in adults with overweight or obesity who also have moderate-to-severe obstructive sleep apnoea OSA treated with positive airway pressure. This Phase 3 study compares NNC0487-0111 to a placebo to see how well it helps reduce body weight and improve sleep apnoea symptoms over time. Participants will be randomly assigned to receive one of these treatments, which are injected under the skin weekly. Participants will receive either one of two dose levels of NNC0487-0111 or a matching placebo injection once a week. Both groups will also follow a reduced-calorie diet and increase physical activity as part of the study. The injections are given using pre-filled pen-injectors at areas such as the thigh, abdomen, or upper arm. The treatment period lasts up to 80 weeks, during which body weight and sleep apnoea severity are closely monitored. Throughout the study, participants will have regular assessments to measure changes in body weight, apnoea-hypopnoea index AHI, sleep quality, blood pressure, blood sugar, cholesterol, and other health markers. Safety is monitored by tracking adverse events until week 84. The study also evaluates improvements in sleep-related symptoms and the potential to reduce or stop positive airway pressure therapy. Total participation may last up to 84 weeks, including follow-up for safety and health outcomes.

Age: 18Years +All GendersPhase 3
92 locations
E

Actively Recruiting

Researchers are evaluating ways to reduce infections after retrograde intrarenal surgery RIRS, a common minimally invasive treatment for kidney stones up to 20 mm. This trial examines the effects of gentamicin-containing irrigation fluid and a suction-enabled ureteral access sheath on postoperative complications such as fever, systemic inflammatory response syndrome SIRS, and sepsis. The study uses a 2x2 factorial design to assess the independent and combined benefits of these two interventions, which target bacterial contamination and elevated intrarenal pressure, respectively. Participants will undergo RIRS under general anesthesia. The study compares four groups standard saline irrigation with a standard ureteral sheath gentamicin added to irrigation fluid with a standard sheath suction-enabled ureteral sheath with standard irrigation and both gentamicin irrigation and suction sheath together. Gentamicin is locally added to irrigation fluid at a dose of 80 mg per 3 L saline bag, while suction-assisted sheaths aim to improve fluid drainage and reduce pressure during the procedure. Stone fragmentation is performed with a holmiumYAG laser, and a ureteral stent is placed afterward. During the study, participants are monitored for infectious outcomes within 48 hours after surgery, including fever, SIRS, and sepsis. Additional assessments include stone-free rates at 4 weeks and changes in blood and urine tests. The trial collects data on urine and blood cultures, white blood cell counts, and kidney function markers. These measures help determine the effects of the interventions on postoperative infection risks and surgical success over the course of follow-up.

Age: 18Years +All GendersPhase Not Applicable
2 locations
C

Actively Recruiting

Total knee arthroplasty TKA is performed for severe knee conditions but often causes intense pain after surgery, which can delay movement, extend hospital stays, and lower patient satisfaction. Researchers are studying two combinations of regional nerve blocks to manage this pain better while preserving muscle strength the adductor canal block ACB with IPACK block and ACB with Biceps Femoris Short Head BiFeS block. This study is prospective, randomized, and aims to compare the effectiveness of these two approaches in controlling postoperative pain under spinal anesthesia. Participants will be divided into two groups receiving ultrasound-guided nerve blocks. One group will get ACB combined with IPACK block, while the other will receive ACB combined with BiFeS block, both using specific doses of bupivacaine. All patients will also receive spinal anesthesia during surgery. The study includes standardized postoperative pain management with paracetamol and patient-controlled tramadol, with rescue fentanyl available as needed. Pain scores and opioid use will be tracked at multiple time points during the first 24 hours after surgery. Participants will undergo regular assessments including pain ratings at rest and movement, muscle strength tests, and monitoring of side effects like nausea and vomiting. Researchers will also record recovery quality, vital signs, time to first mobility, and bowel function. The primary outcome is total opioid consumption in the first 24 hours, with additional measures such as time to first mobilization and motor block incidence. The study will last through the immediate postoperative period with careful monitoring and safety criteria to stop participation if severe pain occurs.

Age: 18Years - 80YearsAll GendersPhase Not Applicable
1 location
E

Actively Recruiting

Researchers are comparing two types of exercise traininghigh-intensity interval training and moderate-intensity continuous trainingto see how they affect functional capacity, muscle strength, and quality of life in adults diagnosed with lipedema. The goal is to find the most effective exercise program for this group of patients. This study is designed as a randomized trial to assess these outcomes over six weeks. Participants will be assigned to one of three groups high-intensity interval aerobic exercise, moderate-intensity continuous aerobic exercise, or a control group that receives exercise recommendations without participating in the training. The exercise sessions last 35 minutes and are performed on a cycle ergometer with specific heart rate targets during warm-up, exercise, recovery, and cool-down periods. During the study, participants will be evaluated for functional capacity, handgrip strength, and health-related quality of life at the start and after six weeks of treatment. Additional assessments include fatigue levels and symptoms of anxiety and depression. The study includes monitoring to track these changes and lasts for six weeks of active treatment with follow-up measurements.

Age: 18Years - 65YearsAll GendersPhase Not Applicable
1 location
C

Actively Recruiting

Researchers are comparing two common noninvasive treatments for lateral epicondylitis, also known as tennis elbow, which causes pain and reduced function in the elbow due to tendon degeneration. This study evaluates the effects of extracorporeal shock wave therapy ESWT and low-level laser therapy LLLT on pain, elbow function, quality of life, grip strength, and tendon structure in adults aged 18 to 65 with symptoms lasting at least six weeks. Participants will receive a tennis elbow brace and follow a standardized exercise program. They will be randomly assigned to receive either ESWT once weekly for 3 weeks using a specific protocol or LLLT three times per week for 3 weeks at defined points on the elbow. Both treatments target the lateral epicondyle region over the common extensor tendon. No other physical therapies or treatment changes are allowed during the study. Before and after the 3-week treatment period, participants will be assessed for pain using the Visual Analog Scale, elbow function with the Patient-Rated Tennis Elbow Evaluation, quality of life with the Short Form-36, and grip strength using a hand dynamometer. A blinded specialist will perform ultrasound imaging to measure tendon thickness and assess tendon quality. The study aims to compare clinical and structural results between the two therapies while monitoring participant progress throughout.

Age: 18Years - 65YearsAll GendersPhase Not Applicable
1 location
C

Actively Recruiting

This research evaluates different upper extremity aerobic exercise training methods to improve arm function in people with heart failure who have cardiac implantable electronic devices like ICD or CRT. It aims to find the best exercise protocol by comparing high-intensity interval training with moderate-intensity continuous training and lower extremity aerobic training. The study focuses on improving upper extremity functional capacity and overall fitness in this specific group of patients. Participants are randomly assigned to one of three groups high-intensity interval upper extremity exercise, moderate-intensity continuous upper extremity exercise, or lower extremity aerobic exercise. The high-intensity protocol includes warm-up, repeated intervals at 80-90% workload, active rest periods, and cool-down over 20 minutes. The moderate-intensity group exercises continuously at 70-80% workload for 20 minutes. The lower extremity group trains for 40 minutes at 70-80% peak oxygen consumption. During the study, participants maximal and functional arm exercise capacity and cardiorespiratory fitness are measured at the start and after 8 weeks. Additional assessments include muscle strength, daily living activities, and quality of life. The trial monitors progress and effects of the exercise protocols over 8 weeks to understand which training best supports arm function and overall fitness in heart failure patients with implantable devices.

Age: 18Years +All GendersPhase Not Applicable
1 location
C

Actively Recruiting

This research aims to compare two surgical techniques for managing the hernia sac during laparoscopic repair of an indirect inguinal hernia, a type of groin hernia. It evaluates whether leaving the lower part of the hernia sac in place Primary Abandon of the Sac, PAS results in similar rates of seromaa fluid collection near the surgery siteas the standard technique that fully removes the sac. The study also assesses operation time, pain, quality of life, complications, return to daily activities, and hernia recurrence. Participants will undergo laparoscopic surgery using either the standard transabdominal preperitoneal repair with complete distal sac dissection or the PAS technique where the lower sac is left intact to reduce tissue dissection. Both approaches use mesh to repair the hernia. The study randomly assigns 90 adults to one of the two techniques with equal chance, and surgeons perform the procedures following standardized care methods. Participants will have follow-up visits at 1 day, 7 days, 1 month, 6 months, and 12 months after surgery. The main outcome, seroma presence, is assessed 30 days after surgery through physical exams and ultrasound if needed. Additional evaluations include pain scores, quality of life questionnaires, complication grading, time to return to daily activities, and monitoring for hernia recurrence through 12 months. This allows thorough monitoring of recovery and surgical outcomes over time.

All AgesAll GendersPhase Not Applicable
1 location
C

Actively Recruiting

Researchers are evaluating the clinical, perioperative, and postoperative outcomes of flexible ureterorenoscopy with a direct in-scope suction system DISS compared to standard flexible ureterorenoscopy for patients undergoing retrograde intrarenal surgery RIRS to remove renal or proximal ureteral stones. The study aims to assess postoperative infectious complications such as fever, systemic inflammatory response syndrome SIRS, and sepsis, as well as other factors like operative parameters, length of hospital stay, need for reoperation, and stone-free status assessed four weeks after surgery by non-contrast computed tomography. The study is a single-center, prospective, randomized, parallel-group trial enrolling 70 adults aged 18 to 75 years with a single kidney or proximal ureter stone. Participants are randomly assigned to one of two groups one receiving standard flexible ureterorenoscopy using a 7.5 Fr reusable Storz Flex-X2 ureterorenoscope, and the other receiving flexible ureterorenoscopy with direct in-scope suction using a 7.5 Fr single-use Claritron ureterorenoscope equipped with suction. Both groups use a 9.511.5 Fr ureteral access sheath, HolmiumYAG laser lithotripsy, and normal saline irrigation. Procedures are performed under general anesthesia with the irrigation bag positioned about 100 cm above the patient. During the study, clinical data including operative time, fluoroscopy time, laser energy used, hospital stay length, and reoperation need are recorded. Laboratory tests such as white blood cell count, C-reactive protein, creatinine, and culture results are collected during follow-up. The study monitors postoperative fever within 48 hours, SIRS, and sepsis, as well as stone-free status about four weeks after surgery. Treatment details for infectious complications, antibiotic use, and intensive care requirements are also documented to evaluate safety and effectiveness of the two surgical approaches.

Age: 18Years - 75YearsAll GendersPhase Not Applicable
1 location

1-10 of 22

1